What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process
- PMID: 25849568
- PMCID: PMC4388504
- DOI: 10.1371/journal.pone.0122246
What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process
Abstract
Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (≥ 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.
Conflict of interest statement
Figures
Similar articles
-
STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.Age Ageing. 2017 Jul 1;46(4):600-607. doi: 10.1093/ageing/afx005. Age Ageing. 2017. PMID: 28119312
-
Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.Res Social Adm Pharm. 2018 Jan;14(1):18-25. doi: 10.1016/j.sapharm.2017.01.003. Epub 2017 Jan 28. Res Social Adm Pharm. 2018. PMID: 28214150
-
Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.PLoS One. 2016 Aug 12;11(8):e0161248. doi: 10.1371/journal.pone.0161248. eCollection 2016. PLoS One. 2016. PMID: 27517450 Free PMC article.
-
Rational deprescribing in the elderly.Ann Clin Psychiatry. 2019 May;31(2):144-152. Ann Clin Psychiatry. 2019. PMID: 31046036 Review.
-
Deprescribing medications in older people: a narrative review.Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495. Drugs Today (Barc). 2018. PMID: 30209443 Review.
Cited by
-
Setback distances for unconventional oil and gas development: Delphi study results.PLoS One. 2018 Aug 16;13(8):e0202462. doi: 10.1371/journal.pone.0202462. eCollection 2018. PLoS One. 2018. PMID: 30114206 Free PMC article.
-
DREAMeR: Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review; study protocol of a randomised controlled trial.BMC Geriatr. 2018 Aug 24;18(1):190. doi: 10.1186/s12877-018-0877-1. BMC Geriatr. 2018. PMID: 30143003 Free PMC article. Clinical Trial.
-
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.Can Fam Physician. 2018 Jan;64(1):17-27. Can Fam Physician. 2018. PMID: 29358245 Free PMC article. Review.
-
Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.Drugs Aging. 2016 Apr;33(4):249-66. doi: 10.1007/s40266-016-0354-5. Drugs Aging. 2016. PMID: 26915076 Review.
-
Defining key questions for clinical practice guidelines: a novel approach for developing clinically relevant questions.Health Res Policy Syst. 2020 Sep 29;18(1):113. doi: 10.1186/s12961-020-00628-3. Health Res Policy Syst. 2020. PMID: 32993665 Free PMC article.
References
-
- Welch GH, Schwartz LM, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Press; 2011.
-
- Godlee F. Preventing overdiagnosis. BMJ. 2012;344: e3783 10.1136/bmj.e3783 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical